Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9662342 | EUGIA PHARMA SPECLTS | Formulations of cyclophosphamide liquid concentrate |
Jun, 2035
(11 years from now) |
Market Authorisation Date: 25 August, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10849916 | DR REDDYS | Stable liquid formulations of cyclophosphamide and its impurities |
Jul, 2035
(11 years from now) | |
US11382923 | DR REDDYS | Stable liquid formulations of cyclophosphamide and processes to prepare the same |
Dec, 2035
(11 years from now) |
Market Authorisation Date: 07 June, 2023
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10993952 | INGENUS PHARMS LLC | Stable ready to use cyclophosphamide liquid formulations |
Feb, 2036
(11 years from now) |
Market Authorisation Date: 30 July, 2020
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS